PEDIATRIC PALLIATIVE CARE DRUGS MARKET ANALYSIS

Market News

Global Pediatric Palliative Care Drugs Market: Key Developments

On July 14, 2022, the U.S. FDA approved Crizotinib [Xalkori] for the treatment of adult and pediatric patients 1 year of age and older with unresectable, recurrent, or refractory Inflammatory Myofibroblastic Tumor (IMT) that is ALK-positive. The approval is given to PF PRISM CV, a subsidiary of Pfizer Inc., a U.S.-based multinational pharmaceutical and biotechnology corporation.

On August 27, 2020, LHC Group, Inc., a U.S. based health care facilities provider, announced a collaboration with University Health Care System, a U.S.-based healthcare system. The agreement is to form a new joint venture to enhance home health and hospice services across eight cities in Georgia and South Carolina. With this agreement, LHC Group will purchase majority ownership and assume management responsibility of University Health Care System.

On September 23, 2022, European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorization for the medicinal product crizotinib (Xalkori). The marketing authorization holder for this medicinal product is Pfizer Inc. CHMP adopted two new indications for the treatment of pediatric patients with Anaplastic Large Cell Lymphoma (ALCL) or Inflammatory Myofibroblastic Tumour (IMT).

On August 17, 2022, the government of Canada announced US$ 2 million in support for palliative care for persons who are homeless or vulnerably housed. This funding will allow Healthcare Excellence Canada (HEC), working with partner organizations, such as the Canadian Partnership Against Cancer (CPAC), to help improve the delivery of palliative care services so that people experiencing homelessness or who are vulnerably housed receive safe, timely, appropriate care in the place of their choosing. Hospice palliative care is a critical part of the health care continuum, improving quality of life for as long as possible. Care is provided wherever the person is, be it in a facility or in their community.